Marco Solmi

Dr. Marco Solmi's main area of interest is epidemiological and evidence-based psychiatry, leveraging both meta-research techniques and national databases to answer clinically relevant questions. Clinically, he is most interested in prevention/early interventions for mental disorders, psychopharmacology, and physical health in those with mental disorders. He has experience in coordinating large international project, as co-PI of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT), an online survey translated in 30 languages involving over 230 researchers from over 50 countries measuring functioning and physical and mental health in the general population during COVID-19 pandemic (www.coh-fit.com).
 

The SCIENCES lab, headed by Dr. Marco Solmi, focuses on epidemiology studies and evidence synthesis projects in the areas of COVID-19, physical health among those with mental health disorders, the effectiveness and safety of biological and psychosocial treatments for mental health disorders, and eating disorders. 

Dr. Solmi's current research activities include:

1. U-REACH (www.u-reach.org) is an open-access platform aimed at providing up-to-date findings generated from umbrella reviews to facilitate accessing knowledge on psychopharmacology for wide range of stakeholders such as researchers, clinicians, policy-makers, and people with lived and living experience.
2. Real world evidence studies form international cohorts on risk prediction
3. Real world evidence studies form international cohorts on psychopharmacology response prediction
4. Disparities in physical healthcare for those with and without mental disorders